Nooms Microdose GLP-1 Rx Program is based on several scientific principles: Self-efficacy boosts success
By September 2025, the FDA had issued more than 50 warning letters to GLP-1 compounders and manufacturers with confirmed DOJ involvement, and 40-plus state attorneys general formally petitioned the FDA about counterfeit peptides entering the US market
The Grant of Excellence Departments, MUR (ARTICOLO 1, COMMI 314 337 LEGGE 232/2016) to the Department of Science, Roma Tre University
Race And Ethnicity Race and ethnicity had no effect on the pharmacokinetics of liraglutide based on the results of population pharmacokinetic analyses that included overweight and obese patients of White, Black or African American, Asian and Hispanic/Non-Hispanic Ethnic groups
Liquid L-thyroxine versus tablet L-thyroxine in patients on L- thyroxine replacement or suppressive therapy: a meta-analysis
These findings suggest that if glycemic control goals are not achieved with oral semaglutide, dosage escalation, with continued use for at least 90 days (equivalent to the 1st visit in this study), should be considered, provided it is tolerated